| The electrostimulation and scar inhibition effect of chitosan/oxidized hydroxyethyl cellulose/reduced graphene oxide/asiaticoside liposome based hydrogel on peripheral nerve … F Zheng, R Li, Q He, K Koral, J Tao, L Fan, R Xiang, J Ma, N Wang, Y Yin, ... Materials Science and Engineering: C 109, 110560, 2020 | 67 | 2020 |
| PKB/Akt partners with Dab2 in albumin endocytosis K Koral, E Erkan American Journal of Physiology-Renal Physiology 302 (8), F1013-F1024, 2012 | 50 | 2012 |
| Pharmacologic inhibition of epidermal growth factor receptor suppresses nonalcoholic fatty liver disease in a murine fast‐food diet model B Bhushan, S Banerjee, S Paranjpe, K Koral, WM Mars, JW Stoops, A Orr, ... Hepatology 70 (5), 1546-1563, 2019 | 46 | 2019 |
| Leukocyte‐S pecific P rotein 1: AN ovel R egulator of H epatocellular P roliferation and M igration D eleted in H uman H epatocellular C arcinoma K Koral, S Paranjpe, WC Bowen, W Mars, J Luo, GK Michalopoulos Hepatology 61 (2), 537-547, 2015 | 29 | 2015 |
| Akt recruits Dab2 to albumin endocytosis in the proximal tubule K Koral, H Li, N Ganesh, MJ Birnbaum, KR Hallows, E Erkan American Journal of Physiology-Renal Physiology 307 (12), F1380-F1389, 2014 | 29 | 2014 |
| The clinical application of camrelizumab on advanced hepatocellular carcinoma Z Chen, X Lu, K Koral Expert Review of Gastroenterology & Hepatology 14 (11), 1017-1024, 2020 | 21 | 2020 |
| The role of fibroblast growth factor 19 in hepatocellular carcinoma Z Chen, L Jiang, L Liang, K Koral, Q Zhang, L Zhao, S Lu, J Tao The American Journal of Pathology 191 (7), 1180-1192, 2021 | 19 | 2021 |
| A noncanonical role for plasminogen activator inhibitor type 1 in obesity-induced diabetes GM Coudriet, J Stoops, AV Orr, B Bhushan, K Koral, S Lee, DM Previte, ... The American journal of pathology 189 (7), 1413-1422, 2019 | 14 | 2019 |
| Surufatinib for the treatment of advanced extrapancreatic neuroendocrine tumors X Lu, S Yan, KA Koral, Z Chen Expert Review of Anticancer Therapy 21 (9), 917-926, 2021 | 13 | 2021 |
| Tissue-type plasminogen activator suppresses activated stellate cells through low-density lipoprotein receptor-related protein 1 LI Kang, K Isse, K Koral, WC Bowen, S Muratoglu, DK Strickland, ... Laboratory investigation 95 (10), 1117-1129, 2015 | 11 | 2015 |
| Yes‐associated protein is crucial for constitutive androstane receptor‐driven hepatocyte proliferation but not for induction of drug metabolism genes in mice B Bhushan, L Molina, K Koral, JW Stoops, WM Mars, S Banerjee, A Orr, ... Hepatology 73 (5), 2005-2022, 2021 | 10 | 2021 |
| Yap is crucial for CAR-driven hepatocyte proliferation, but not for induction of drug metabolism genes in mice B Bhushan, L Molina, K Koral, JW Stoops, WM Mars, S Banerjee, A Orr, ... Hepatology (Baltimore, Md.) 73 (5), 2005, 2021 | 5 | 2021 |
| PDLLA/β-TCP/HA/CHS/NGF Sustained-release Conduits for Peripheral Nerve Regeneration X Yan, J Wang, Q He, H Xu, J Tao, K Koral, K Li, J Xu, J Wen, Z Huang, ... Journal of Wuhan University of Technology-Mater. Sci. Ed. 36, 600-606, 2021 | 3 | 2021 |
| Lymphocyte-specific protein-1 controls sorafenib sensitivity and hepatocellular proliferation through extracellular signal-regulated kinase 1/2 activation K Koral, M Haynes, WC Bowen, A Orr, W Mars, GK Michalopoulos The American Journal of Pathology 188 (9), 2074-2086, 2018 | 3 | 2018 |
| Lymphocyte-Specific Protein-1 Suppresses Xenobiotic-Induced Constitutive Androstane Receptor and Subsequent Yes-Associated Protein–Activated Hepatocyte Proliferation K Koral, B Bhushan, A Orr, J Stoops, WC Bowen, MA Copeland, J Locker, ... The American Journal of Pathology 192 (6), 887-903, 2022 | 2 | 2022 |
| Glypican 3 (GPC3)‐CD81 axis regulates spleen tyrosine kinase (Syk)‐Ezrin mediated Hippo pathway via cross talking with HGF/c‐Met axis in hepatocytes and hepatocellular … Y Xue, W Bowen, K Koral, A Orr, W Mars, G Michalopoulos The FASEB Journal 31, 805.2-805.2, 2017 | 1 | 2017 |
| GPC3‐CD81 axis in the HCV mediated liver carcinogenesis Y Xue, B Bowen, A Orr, K Koral, M Haynes, A Bell, S Paranjpe, W Mars, ... The FASEB Journal 29, 611.9, 2015 | 1 | 2015 |
| PHENOBARBITAL INDUCES HEPATOCELLULAR NECROSIS AND COMPENSATORY PROLIFERATION IN LYMPHOCYTE SPECIFIC PROTEIN-1 DEFICIENT MICE K Koral, B Bhushan, A Orr, W Bowen, J Stoops, J Locker, WM Mars, ... HEPATOLOGY 74, 290A-291A, 2021 | | 2021 |
| TCPOBOP INDUCED HEPATOCELLULAR PROLIFERATION IS ATTENUATED BY LYMPHOCYTE SPECIFIC PROTEIN-1 K Koral, B Bhushan, J Stoops, A Orr, WM Mars, GK Michalopoulos The Liver Meeting Digital Experience™, 2020 | | 2020 |
| Lymphocyte Specific Protein‐1 suppresses TCPOBOP induced hepatocellular proliferation K Koral, B Bhushan, J Stoops, A Orr, W Mars, G Michalopoulos The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
